ABSTRACT
Introduction The profound impact of wounds on the quality of life of those affected is often underestimated. Chronic wounds impose substantial burdens on individuals and communities in terms of disability, mental distress, stigma, and economic productivity losses. To effectively address these challenges, an integrated and comprehensive approach to primary healthcare-based chronic wound care prevention and management is essential. This implementation research study aims to assess the integration and scale-up of a comprehensive package of primary healthcare-based wound care and psycho-social support for persons affected by chronic wounds caused by neglected tropical diseases (NTDs) and other conditions in selected districts in Ethiopia.
Methods The study will be implemented in Central Ethiopia in three stages, utilizing a mixed-methods approach to co-develop a comprehensive care package and progressively implement the care package building on learnings from successive stages of implementation. Stage 1 will encompass the co-development of a holistic wound care package and strategies for its integration into routine health services. Stage 2 will involve a pilot study in one sub-district, to establish the care package adoption, feasibility, acceptability, fidelity, potential effectiveness, readiness for scale-up, and costs. Stage 3 will involve the scale-up of the wound care package and its evaluation in several districts.
Ethics and dissemination Ethics approval was obtained for the study from the relevant authorities in both the UK (Ref no: ER-BSMS9D79-6) and Ethiopia [Reference no. 013/23/CDT]. The results of the study will be disseminated through a variety of channels, including publications in scientific journals, conference presentations, policy briefs, and workshops. This will ensure that the findings are disseminated widely to the scientific community, policymakers, and the public.
Strengths
This study will address a critical gap in Ethiopia, where there is a significant health burden due to chronic wounds from skin-NTDs and other conditions, for which primary healthcare integration of wound care could improve accessibility and outcomes for affected persons, their families and communities.
The study will use implementation research methods to examine the integration and scale-up of a primary healthcare-based package for wound care and psychosocial support, which is crucial for wider adoption and sustainability.
The use of a mixed-methods design will enable a comprehensive understanding of the care package’s feasibility and effectiveness.
Limitations
Lack of a comparison group (i.e. control group).
Whilst the study will include provision of essential medical supplies to bridge local shortages and support disadvantaged patients, provision of care after the study period is beyond the scope of this study. However, the study team will work closely with the local health administration and the Ministry of Health to ensure the sustainability of services.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This research was funded by the National Institute for Health and Care Research (NIHR) Global Health Research Unit on NTDs at the Brighton & Sussex Medical School
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Addis Ababa University,College of health sciences, Institutional Research Ethics Review Committee and Brighton and Sussex Medical School Research Governance Ethics Committee gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in this study will be available upon reasonable request to the authors.
